TRMT10A-Related Disorder: A Patient Guide
At a Glance
TRMT10A-related disorder is a rare inherited condition that can affect head growth, development, height, and blood sugar. Diabetes often begins in the preteen years or early adulthood rather than at birth, so ongoing developmental and blood-sugar monitoring is important.
TRMT10A-related disorder is an exceptionally rare genetic condition that primarily affects three areas of a person’s health: the way the brain develops, how the body grows, and how the pancreas regulates blood sugar. Because this condition is autosomal recessive, a person only develops it if they inherit a non-working copy of the TRMT10A gene from both parents, who are usually healthy carriers. This genetic change interferes with the cell’s ability to protect and maintain specific tissues, leading to a unique combination of symptoms that doctors often refer to as primary microcephaly-mild intellectual disability-young-onset diabetes syndrome [1][2]. This guide is intended to help parents, caregivers, and affected individuals who are managing their own care understand and navigate this condition.
In the brain and body, this disorder typically shows itself early through microcephaly (a head size smaller than expected) and developmental delays. Most children reach milestones like walking and talking later than their peers and may experience mild intellectual disability. However, based on the limited number of reported individuals, progressive neurodegeneration or consistent regression has not been a prominent reported pattern; individuals typically continue to gain new skills and learn at their own pace. Any loss of acquired skills warrants prompt medical evaluation. While some individuals may also develop epilepsy (seizures), these neurological features are often the focus of early intervention and support through therapies and specialized education [3][4].
The metabolic and growth aspects of the disorder follow a much more variable timeline, often emerging later in childhood or even early adulthood. Many individuals experience short stature, which can sometimes be linked to a lack of growth hormone. Perhaps most uniquely, the young-onset diabetes associated with this condition is not typically present at birth. Instead, it can appear anytime from the pre-teen years into the early 20s. This means that even if a child’s or young adult’s blood sugar is currently healthy, lifelong monitoring is a standard part of their care, as the timing and severity of these metabolic changes can vary significantly from one person to another [5][6].
Living with a TRMT10A diagnosis means navigating a complex and often unpredictable path, but it also means having a clear roadmap for what to monitor. By partnering with a team of specialists—including pediatric or adult endocrinologists and neurologists—individuals and parents can proactively manage health and provide the targeted support needed. While the rarity of the condition can feel overwhelming, understanding the underlying biology allows families and medical teams to shift from searching for answers to focusing on the long-term well-being and growth of the individual [2][7].
In this guide
6 chapters
Understanding Your Diagnosis: TRMT10A-Related Disorder
Learn what TRMT10A-related disorder means for your child, including microcephaly, developmental delay, diabetes risk, seizures, growth and long-term monitoring.
Symptoms and Evolving Features
Learn how TRMT10A-related disorder symptoms change with age, including growth, seizures, low blood sugar, diabetes, puberty, and emergency warning signs.
The Science of TRMT10A: Genetics and Biology
Learn how TRMT10A-related disorder affects brain and pancreatic cells, how it is inherited, and which genetic tests confirm the diagnosis versus diabetes mimics.
Managing Diabetes and Hormones
Learn how TRMT10A-related disorder affects diabetes, growth, puberty, and blood sugar. Review monitoring, insulin, growth hormone, and care-team questions for families.
Neurological and Developmental Care
Learn how TRMT10A-related disorder affects development, microcephaly, and seizures, including therapies, EEG and MRI testing, seizure care, and school support for families.
Building Your Care Team & Long-Term Monitoring
Learn how TRMT10A-related disorder teams monitor blood sugar, growth, puberty, seizures, kidney health, and development, with tips for coordinating care.
Common questions in this guide
What is TRMT10A-related disorder?
What developmental and physical features can TRMT10A-related disorder cause?
When does diabetes usually develop with TRMT10A-related disorder?
Does TRMT10A-related disorder cause loss of skills over time?
Which specialists and supports may help manage TRMT10A-related disorder?
How is TRMT10A-related disorder inherited?
Get notified when new evidence is published on Primary microcephaly-mild intellectual disability-young-onset diabetes syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (7)
- 1
Expanding the Phenotype of TRMT10A Mutations: Case Report and a Review of the Existing Cases
Şıklar Z, Kontbay T, Colclough K, et al.
Journal of clinical research in pediatric endocrinology 2023; (15(1)):90-96 doi:10.4274/jcrpe.galenos.2021.2021.0110.
PMID: 34541035 - 2
TRMT10A-Related Neurodevelopmental Disorder Without Metabolic Findings.
Ülker Üstebay D, Aksu Şahin İ, Üstebay S, et al.
Human mutation 2026; (2026()):8058409 doi:10.1155/humu/8058409.
PMID: 42181738 - 3
tRNA methyltransferase homologue gene TRMT10A mutation in young adult-onset diabetes with intellectual disability, microcephaly and epilepsy.
Yew TW, McCreight L, Colclough K, et al.
Diabetic medicine : a journal of the British Diabetic Association 2016; (33(9)):e21-5 doi:10.1111/dme.13024.
PMID: 26526202 - 4
Case Report: Compound heterozygous nonsense mutations in TRMT10A are associated with microcephaly, delayed development, and periventricular white matter hyperintensities.
Narayanan M, Ramsey K, Grebe T, et al.
F1000Research 2015; (4()):912 doi:10.12688/f1000research.7106.1.
PMID: 26535115 - 5
tRNA methyltransferase 10 homologue A (TRMT10A) mutation in a Chinese patient with diabetes, insulin resistance, intellectual deficiency and microcephaly.
Lin H, Zhou X, Chen X, et al.
BMJ open diabetes research & care 2020; (8(1)) doi:10.1136/bmjdrc-2020-001601.
PMID: 33067246 - 6
Homozygous deletion of TRMT10A as part of a contiguous gene deletion in a syndrome of failure to thrive, delayed puberty, intellectual disability and diabetes mellitus.
Zung A, Kori M, Burundukov E, et al.
American journal of medical genetics. Part A 2015; (167A(12)):3167-73 doi:10.1002/ajmg.a.37341.
PMID: 26297882 - 7
Discovery of a TRMT10A mutation in a case of atypical diabetes: Case report.
Samhani C, Guerci B, Larose C
Diabetes & metabolism 2024; (50(6)):101572 doi:10.1016/j.diabet.2024.101572.
PMID: 39243962
This TRMT10A-related disorder page is for informational purposes only and does not constitute medical advice. An endocrinologist, neurologist, and other members of the healthcare team can tailor developmental and blood-sugar monitoring to the individual.